Patent details

Basic Information

Publication number:

EP2841084

PCT Application Number:

IL2013050352

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137276572

PCT Publication Number:

WO2013160895

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CXCR4 ANTAGONIST PEPTIDE FOR USE IN THE TREATMENT OF LARGE CELL LUNG CANCER

French Title of Invention:

PEPTIDE ANTAGONISTE DE CXCR4 ET SON UTILISATION POUR LE TRAITMENT DE TUMEURS PULMONAIRES

German Title of Invention:

CXCR4 ANTAGONIST PEPTID ZUR VERWENDUNG IN DER BEHANDLUNG VON LUNGENKREBS

SPC Number:

Dates

Filing date:

24/04/2013

Grant date:

30/05/2018

EP Publication Date:

04/03/2015

PCT Publication Date:

31/10/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/05/2018

EP B1 Publication Date:

30/05/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/04/2019

Expiration date:

24/04/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/05/2018

 

 

Name:

Biokine Therapeutics Ltd.

Address:

Building 13a Einstein Street, Science Park Kiryat Weizmann, 70400 Nes Ziona, Israel (IL)

Inventor

1

Name:

WALD, Ori

Address:

Israel (IL)

2

Name:

PELED, Amnon

Address:

Israel (IL)

Priority

Priority Number:

201261637334 P

Priority Date:

24/04/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/282; A61K 31/337; A61K 38/10; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

201822

Publication date:

30/05/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages